首页> 外文期刊>BMC Microbiology >Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori -stimulated gastric epithelial cells
【24h】

Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori -stimulated gastric epithelial cells

机译:能够抑制幽门螺杆菌刺激的胃上皮细胞中IL-8产生的唾液乳杆菌B37和B60菌株的表征

获取原文
       

摘要

Background Interleukin (IL)-8 is the key agent for initiating an inflammatory response to infection with Helicobacter pylori . Some strains of Lactobacillus spp. are known to colonize the stomach and suppress inflammation caused by H. pylori . In this study, we characterized two gastric-derived lactobacilli, Lactobacillus salivarius (LS) strains B37 and B60, capable of inhibiting H. pylori -induced IL-8 production by gastric epithelial cells. Results Conditioned media from LS-B37 and LS-B60 suppressed H. pylori -induced IL-8 production and mRNA expression from AGS cells without inhibiting H. pylori growth. These conditioned media suppressed the activation of NF-κB but did not suppress c-Jun activation. IL-8 inhibitory substances in conditioned media of LS-B37 and LS-B60 are heat-stable and larger than 100?kDa in size. The inhibitory activity of LS-B37 was abolished when the conditioned medium was treated with α-amylase but still remained when treated with either proteinase K, trypsin, lipase or lysozyme. The activity of LS-B60 was abolished when the conditioned medium was treated with either amylase or proteinase K but still remained when treated with lysozyme. Treatment with lipase and trypsin also significantly affected the inhibitory activity of LS-B60 although the conditioned medium retained IL-8 suppression statistically different from media control. Conclusions These results suggest that L. salivarius strains B37 and B60 produce different immunomodulatory factors capable of suppressing H. pylori- induced IL-8 production from gastric epithelial cells. Our results suggest that the large, heat-stable immunomodulatory substance(s) present in the LCM of LS-B37 is a polysaccharide, while the one(s) of LS-B60 is either complex consisting of components of polysaccharide, lipid and protein or includes multiple components such as glycoprotein and lipoprotein.
机译:背景白介素(IL)-8是引发针对幽门螺杆菌感染的炎症反应的关键药物。乳酸杆菌属的一些菌株。已知可以殖民胃和抑制幽门螺杆菌引起的炎症。在这项研究中,我们表征了两个胃源性乳酸杆菌,唾液乳杆菌(LS)菌株B37和B60,它们能够抑制幽门螺杆菌诱导的胃上皮细胞产生IL-8。结果来自LS-B37和LS-B60的条件培养基抑制了幽门螺杆菌诱导的AGS细胞IL-8产生和mRNA表达,而没有抑制幽门螺杆菌的生长。这些条件培养基抑制了NF-κB的激活,但没有抑制c-Jun的激活。 LS-B37和LS-B60的条件培养基中的IL-8抑制物质是热稳定的,并且大小大于100?kDa。当用α-淀粉酶处理条件培养基时,LS-B37的抑制活性消失,但是当用蛋白酶K,胰蛋白酶,脂肪酶或溶菌酶处理时,LS-B37的抑制活性仍然保留。当用淀粉酶或蛋白酶K处理条件培养基时,LS-B60的活性被消除,但是当用溶菌酶处理时,LS-B60的活性仍然保留。用脂肪酶和胰蛋白酶处理也显着影响了LS-B60的抑制活性,尽管条件培养基保留了IL-8抑制作用,其统计学上与培养基对照不同。结论这些结果表明,唾液乳杆菌菌株B37和B60产生了不同的免疫调节因子,能够抑制幽门螺杆菌诱导的胃上皮细胞产生IL-8。我们的结果表明,存在于LS-B37的LCM中的大型,热稳定的免疫调节物质是多糖,而LS-B60的一种是由多糖,脂质和蛋白质组成的复合物或包括多种成分,例如糖蛋白和脂蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号